Pittsburgh, PA, United States of America

Garth S Jones

This inventor holds 1 USPTO granted patent. Top assignee: University of Pittsburgh. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Garth S Jones. Retrieved from https://idiyas.com/inventor/garth-s-jones-iawcubb3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Garth S. Jones

Introduction

Garth S. Jones, an accomplished inventor based in Pittsburgh, PA, has made significant contributions to the field of pharmacotherapy through his unique approach to adenosine analogues. His innovative ideas have led to the development of compounds that show great potential in treating various medical conditions.

Latest Patents

Jones holds a patent titled "Adenosine cyclic ketals: novel adenosine analogues for pharmacotherapy." This groundbreaking invention focuses on novel compounds that function as both adenosine receptor agonists and ganglionic blocking agents. These compounds are designed with a ganglionic blocking motif that includes an elongated carbon chain, specifically engineered to enhance their therapeutic efficacy. The elongated carbon chain, which may range from two to sixteen carbons in length, is integral to the cyclic ketal structure of the adenosine molecule. This innovative approach holds promise for the treatment of conditions such as hypertension, vasodilation, and ischemia.

Career Highlights

Garth S. Jones is currently affiliated with the University of Pittsburgh, where he has been instrumental in advancing research in pharmacotherapy. His work on adenosine analogues not only emphasizes his inventive spirit but also reflects his dedication to improving medical interventions.

Collaborations

Throughout his career, Jones has collaborated with Edwin Kerry Jackson, another notable figure in the research community. Their joint efforts contribute to the exploration of creative solutions within the domain of pharmacology, highlighting the importance of teamwork in driving innovation forward.

Conclusion

Garth S. Jones exemplifies the innovative prowess of modern inventors in the field of pharmacotherapy. His patent on adenosine cyclic ketals showcases his ability to blend scientific knowledge with practical application, ultimately aiming to improve health outcomes. As research progresses, the contributions of inventors like Jones will continue to pave the way for advancements that can significantly enhance our understanding and treatment of various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…